medigraphic.com
SPANISH

Salud Pública de México

Instituto Nacional de Salud Pública
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2002, Number 1

Next >>

salud publica mex 2002; 44 (1)

The medical care costs of hypertension and their impact on health care resources in Mexico.

Villarreal-Ríos E, Mathew-Quiroz A, Garza-Elizondo ME, Núñez-Rocha G, Salinas-Martínez AM, Gallegos-Handal M
Full text How to cite this article

Language: Spanish
References: 12
Page: 7-13
PDF size: 99.08 Kb.


Key words:

cost, hypertension, utilization, Mexico.

ABSTRACT

Objective. To assess the medical care costs of hypertension and their impact on the health care expenditures and on Mexico’s Gross National Product (GNP). Material and Methods. An ecological study was conducted from June to November 1999, at Instituto Mexicano del Seguro Social (Mexican Institute of Social Security, IMSS), in Monterrey, Nuevo Leon, Mexico. A random sample of medical charts of patients with hypertension was selected, to extract data on utilization of health services and unitary costs per care episode. The cost per care episode and per hypertensive patient was calculated by adjusting the unitary cost as a function of standard and extreme utilization of IMSS health services. The resulting figure was then projected to the total population of hypertensive patients and compared to the annual health care expenditures of Mexico. Results. The annual cost per patient with hypertension was $1,067 in the standard scenario and $3,913 in the extreme scenario. The annual expenditures from hypertension corresponded to 13.95% of the budget allocated to health care and to 0.71%, of Mexico’s GNP. These figures changed to 51.17% and 2.61% in the extreme scenario, respectively. Conclusions. The costs of hypertension medical care account for a good portion of healthcare resources. This problem should be analyzed by multidisciplinary health teams in search of more efficient medical care alternatives.


REFERENCES

  1. National Health and Nutrition Examination Survey III, 1988-1991 CDS/NCHS.

  2. Joffres MR. Awarness, treatment and control of hypertension in Canada Amer JJ Hypertens 1997; 10:1097-1102.

  3. Secretaría de Salud. Encuesta Nacional de Enfermedades Crónicas. Tercera Edición, México D.F.; SSA, 1996.

  4. Sistema Unico de Información. Epidemiología. Sistema Nacional de Vigilancia Epidemiológica. Número 52, Vol 16, Semana 52, del 26 de diciembre de 1999 al 1 de enero de 2000.

  5. Calvo VC. Nuevos retos del control de la hipertensión arterial. Rev Med Instituto Mexicano del Seguro Social 1998; 36(3):199-201.

  6. Villarreal Ríos E, Cavazos Galván RH, Garza Elizondo ME, Guzmán Padilla JE, Montalvo Almaguer G, Salinas Martínez AM et al. Estimación de costos en salud: una propuesta metodológica. “Modelo de presupuesto capitado” Instituto Mexicano del Seguro Social, Dirección Regional Norte, Coordinación Regional de Comunicación Social. México, D.F. 1997.

  7. Secretaría de Salud. Boletín de Información Estadística. Recursos y Servicios, Nº 16, vol 1. Sistema Nacional de Salud. México, 1996.

  8. Villarreal-Ríos E, Salinas-Martínez A, Garza-Elizondo ME, Núñez-Rocha GM. Estructura del Mercado de los Servicios de Salud en México. Rev Inst Mex Seguro Soc 2000;38(5): 365-369.

  9. Hernández P, Zurita B, Ramírez R, Alvarez F, Cruz C. Las cuentas nacionales de salud. 1995. México, D.F.: Fundación Mexicana para la Salud (Funsalud), 1997.

  10. Instituto Mexicano del Seguro Social. Compendio estadístico anual de oferta y demanda, servicios médicos otorgados y morbi-mortalidad en Nuevo León. Coordinación Delegacional de Informática Médica. Jefatura Delegacional de Prestaciones Médicas. Delegación Regional Nuevo León. Instituto Mexicano del Seguro Social. Monterrey, N.L., 1998.

  11. McMurray J. The health economics of the treatment of hyperlipidemia and hypertension. Am J Hypertens 1999;(12): 99-104.

  12. Shepard D, Hodgkin D. Cost effectiveness of intensive treatment of hypertension. AM J Manag Care 1998: 765-769.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

salud publica mex. 2002;44